Bausch Health Companies (BHC) Asset Utilization Ratio (2010 - 2026)
Bausch Health Companies' (BHC) quarterly Asset Utilization Ratio came in at 0.41 in Q1 2026, up 12.65% year-on-year from 0.37 in Q1 2025, and up 7.27% quarter-over-quarter from 0.39 in Q4 2025.
Bausch Health Companies (BHC) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Asset Utilization Ratio across 17 years of filings, most recently posting 0.41 for Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.41, up 12.65% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.41 (up 12.65% YoY), and the FY2025 annual result was 0.39, up 8.64% from the prior year.
- Asset Utilization Ratio came in at 0.41 for Q1 2026 at Bausch Health Companies, up from 0.39 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.48 in Q3 2022 to a low of 0.31 in Q4 2022.
- The 5-year median for Asset Utilization Ratio is 0.36 (2024), against an average of 0.37.
- Across the five-year window, Asset Utilization Ratio jumped 75.09% in 2022 and sank 32.8% in 2023, its largest moves.
- Bausch Health Companies' Asset Utilization Ratio stood at 0.31 in 2022, then grew by 2.98% to 0.32 in 2023, then climbed by 12.71% to 0.36 in 2024, then advanced by 6.41% to 0.39 in 2025, then grew by 7.27% to 0.41 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.41 (Q1 2026), 0.39 (Q4 2025), and 0.37 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.43 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 0.62 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 0.43 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.48 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 0.65 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.37 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 0.36 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.68 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.07 |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | 0.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.41 |
| Dec 31, 2025 | 0.39 |
| Sep 30, 2025 | 0.37 |
| Jun 30, 2025 | 0.37 |
| Mar 31, 2025 | 0.37 |
| Dec 31, 2024 | 0.36 |
| Sep 30, 2024 | 0.36 |
| Jun 30, 2024 | 0.34 |
| Mar 31, 2024 | 0.33 |
| Dec 31, 2023 | 0.32 |
| Sep 30, 2023 | 0.32 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.31 |
| Sep 30, 2022 | 0.48 |
| Jun 30, 2022 | 0.46 |
| Mar 31, 2022 | 0.46 |
| Dec 31, 2021 | 0.46 |
| Sep 30, 2021 | 0.29 |
| Jun 30, 2021 | 0.28 |